Differential Temporal Dynamics and Motor–Non-Motor Dissociation After Inhaled Levodopa in Parkinson’s Disease: A Post Hoc Analysis of the INLEVO-LIFE PD Study
Open Access
- 17 October 2026
- journal article
- research article
- Published by MDPI AG in Medical Sciences
- Vol. 14 (6) , 680
Abstract
Background/Objectives: OFF episodes in Parkinson’s disease (PD) include motor and non-motor manifestations, but their resolution after on-demand therapy may not be synchronous. We examined within-patient temporal dynamics of motor and non-motor responses after inhaled levodopa. Methods: This post hoc analysis used data from the prospective, multicenter, open-label INLEVO-LIFE PD study. At week 12, UPDRS-III and 10 OFF-related non-motor symptoms (NMSs) were assessed in OFF and 30, 60, and 90 min after inhaled levodopa. The principal post hoc outcome was the proportion of maximum early (30–60 min) benefit retained at 90 min for motor versus non-motor outcomes. Individual trajectories were also examined descriptively. Results: Thirty-four participants had complete serial assessments. Mean UPDRS-III scores were 25.91, 11.21, 12.00, and 16.00 at OFF, 30, 60, and 90 min, respectively (p < 0.0001); corresponding NMSS-OFF/ON total scores were 6.65, 2.09, 1.91, and 2.71 (p < 0.0001). Among 28 participants with early improvement in both outcomes, median benefit retained at 90 min was 67.1% for motor symptoms versus 100% for NMSs (p = 0.0011). Motor and non-motor improvement magnitudes were not significantly correlated at any time point. Individual trajectories showed marked interindividual heterogeneity in the timing and persistence of motor and non-motor responses. Conclusions: Motor and non-motor OFF manifestations improved rapidly after inhaled levodopa but showed partially dissociated temporal trajectories, challenging the assumption that OFF resolution is necessarily synchronous across symptom dimensions. Greater relative persistence of non-motor benefit at 90 min is hypothesis-generating and requires confirmation using validated NMF instruments and controlled designs.Keywords
All Related Versions
Funding Information
- collaboration of Esteve through a donation to the Degen Foundation
This publication has 31 references indexed in Scilit:
- Inhaled Levodopa for the Management of OFF Episodes in Patients with Parkinson’s Disease: A Network Meta-analysisNeurology and Therapy, 2026
- Inhaled levodopa in Parkinson´s disease with motor fluctuations: post-commercialization experience in two movement disorders unitsNeurological Sciences, 2026
- Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approachesJournal of Neural Transmission, 2025
- Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s diseaseJournal of Neural Transmission, 2023
- Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi PanelMovement Disorders Clinical Practice, 2023
- On‐Demand Therapy for OFF Episodes in Parkinson's DiseaseMovement Disorders, 2021
- Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireMovement Disorders, 2021
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideMovement Disorders Clinical Practice, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- A randomized trial of inhaled levodopa (CVT‐301) for motor fluctuations in Parkinson's diseaseMovement Disorders, 2016